RT Journal Article
SR Electronic
T1 Placenta accreta spectrum: a non-oncologic challenge for gynecologic oncologists
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP 788
OP 798
DO 10.1136/ijgc-2021-003325
VO 32
IS 6
A1 Omar Touhami
A1 Lisa Allen
A1 Homero Flores Mendoza
A1 M Alix Murphy
A1 Sebastian Rupert Hobson
YR 2022
UL http://ijgc.bmj.com/content/32/6/788.abstract
AB Placenta accreta spectrum disorders are a major risk factor for severe postpartum hemorrhage and maternal death worldwide, with a rapidly growing incidence in recent decades due to increasing rates of cesarean section. Placenta accreta spectrum disorders represent a complex surgical challenge, with the primary concern of massive obstetrical hemorrhagic sequelae and organ damage, occurring in the context of potentially significant anatomical and physiological changes of pregnancy.  Most international obstetrical organizations have published guidelines on placenta accreta spectrum, embracing the creation of regionalized ‘Centers of Excellence’ in the diagnosis and management of placenta accreta spectrum, which includes a dedicated multidisciplinary surgical team. One mandatory criterion for these Centers of Excellence is the presence of a surgeon experienced in complex pelvic surgeries. Indeed, many institutions in the United States and worldwide rely on gynecologic oncologists in the surgical management of placenta accreta spectrum due to their experience and skills in complex pelvic surgery.  Surgical management of placenta accreta spectrum frequently includes challenging pelvic dissection in regions with distortion of anatomy alongside large aberrant neovascularization. With a goal of definitive management through cesarean hysterectomy, surgeons require a systematic and thoughtful approach to promote prevention of urologic injuries, embrace measures to secure challenging hemostasis and, in selected cases, employ conservative management where indicated or desired.  In this review recommendations are made for gynecologic oncologists regarding the management and important considerations in the successful care of placenta accreta spectrum disorders. Where required, gynecologic oncologists are encouraged to be proactively involved in the management of placenta accreta spectrum, not only intra-operatively, but also in the development of clinical protocols, guidelines, and pre-operative counseling of patients, as a ‘call if needed’ approach is suboptimal for this potentially major and life-threatening condition.